vs

Side-by-side financial comparison of Ascendis Pharma A/S (ASND) and Planet Fitness, Inc. (PLNT). Click either name above to swap in a different company.

Planet Fitness, Inc. is the larger business by last-quarter revenue ($376.3M vs $267.3M, roughly 1.4× Ascendis Pharma A/S). On growth, Ascendis Pharma A/S posted the faster year-over-year revenue change (42.3% vs 10.5%). Over the past eight quarters, Ascendis Pharma A/S's revenue compounded faster (60.7% CAGR vs 23.2%).

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

Planet Fitness, Inc. is an American franchisor and operator of fitness centers based in Hampton, New Hampshire. The company has around 2,715 clubs, making it one of the largest fitness club franchises by number of members and locations. The franchise has locations in the United States, Canada, Panama, Mexico, Spain and Australia. It markets itself as a "Judgement Free Zone" open to all levels of gym users.

ASND vs PLNT — Head-to-Head

Bigger by revenue
PLNT
PLNT
1.4× larger
PLNT
$376.3M
$267.3M
ASND
Growing faster (revenue YoY)
ASND
ASND
+31.8% gap
ASND
42.3%
10.5%
PLNT
Faster 2-yr revenue CAGR
ASND
ASND
Annualised
ASND
60.7%
23.2%
PLNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASND
ASND
PLNT
PLNT
Revenue
$267.3M
$376.3M
Net Profit
$60.4M
Gross Margin
90.5%
76.0%
Operating Margin
28.2%
Net Margin
16.0%
Revenue YoY
42.3%
10.5%
Net Profit YoY
28.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASND
ASND
PLNT
PLNT
Q4 25
$267.3M
$376.3M
Q3 25
$230.7M
$330.3M
Q2 25
$170.7M
$340.9M
Q1 25
$109.0M
$276.7M
Q4 24
$187.8M
$340.4M
Q3 24
$62.5M
$292.2M
Q2 24
$38.9M
$300.9M
Q1 24
$103.6M
$248.0M
Net Profit
ASND
ASND
PLNT
PLNT
Q4 25
$60.4M
Q3 25
$-65.9M
$58.8M
Q2 25
$-42.0M
$58.0M
Q1 25
$-102.2M
$41.9M
Q4 24
$47.1M
Q3 24
$-107.1M
$42.0M
Q2 24
$-118.1M
$48.6M
Q1 24
$-141.5M
$34.3M
Gross Margin
ASND
ASND
PLNT
PLNT
Q4 25
90.5%
76.0%
Q3 25
89.5%
82.4%
Q2 25
80.1%
82.6%
Q1 25
82.6%
91.9%
Q4 24
91.9%
76.4%
Q3 24
80.6%
84.4%
Q2 24
68.2%
82.7%
Q1 24
92.1%
92.3%
Operating Margin
ASND
ASND
PLNT
PLNT
Q4 25
28.2%
Q3 25
5.1%
32.4%
Q2 25
-33.5%
30.0%
Q1 25
-103.2%
28.6%
Q4 24
26.4%
Q3 24
-167.3%
27.8%
Q2 24
-370.2%
29.0%
Q1 24
-51.2%
26.5%
Net Margin
ASND
ASND
PLNT
PLNT
Q4 25
16.0%
Q3 25
-28.5%
17.8%
Q2 25
-24.6%
17.0%
Q1 25
-93.7%
15.1%
Q4 24
13.8%
Q3 24
-171.5%
14.4%
Q2 24
-303.9%
16.2%
Q1 24
-136.6%
13.8%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASND
ASND
PLNT
PLNT
Cash + ST InvestmentsLiquidity on hand
$665.3M
$452.4M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$-175.8M
$-482.8M
Total Assets
$1.4B
$3.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASND
ASND
PLNT
PLNT
Q4 25
$665.3M
$452.4M
Q3 25
$582.2M
$443.4M
Q2 25
$533.6M
$442.7M
Q1 25
$559.4M
$453.6M
Q4 24
$604.3M
$407.3M
Q3 24
$675.6M
$407.4M
Q2 24
$279.4M
$350.2M
Q1 24
$345.9M
$395.1M
Total Debt
ASND
ASND
PLNT
PLNT
Q4 25
$2.5B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.0B
Stockholders' Equity
ASND
ASND
PLNT
PLNT
Q4 25
$-175.8M
$-482.8M
Q3 25
$-188.0M
$-194.8M
Q2 25
$-202.6M
$-158.7M
Q1 25
$-205.0M
$-219.9M
Q4 24
$-114.2M
$-215.4M
Q3 24
$-105.1M
$-266.1M
Q2 24
$-346.8M
$-317.7M
Q1 24
$-257.2M
$-96.4M
Total Assets
ASND
ASND
PLNT
PLNT
Q4 25
$1.4B
$3.1B
Q3 25
$1.2B
$3.1B
Q2 25
$1.2B
$3.1B
Q1 25
$1.1B
$3.1B
Q4 24
$1.3B
$3.1B
Q3 24
$1.2B
$3.0B
Q2 24
$819.0M
$3.0B
Q1 24
$866.7M
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASND
ASND
PLNT
PLNT
Operating Cash FlowLast quarter
$58.2M
$109.1M
Free Cash FlowOCF − Capex
$59.0M
FCF MarginFCF / Revenue
15.7%
Capex IntensityCapex / Revenue
13.3%
Cash ConversionOCF / Net Profit
1.81×
TTM Free Cash FlowTrailing 4 quarters
$254.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASND
ASND
PLNT
PLNT
Q4 25
$58.2M
$109.1M
Q3 25
$131.5M
Q2 25
$44.0M
Q1 25
$-15.5M
$133.9M
Q4 24
$-330.7M
$49.1M
Q3 24
$126.8M
Q2 24
$78.2M
Q1 24
$-109.7M
$89.7M
Free Cash Flow
ASND
ASND
PLNT
PLNT
Q4 25
$59.0M
Q3 25
$76.7M
Q2 25
$8.2M
Q1 25
$110.9M
Q4 24
$7.0M
Q3 24
$78.2M
Q2 24
$40.2M
Q1 24
$63.4M
FCF Margin
ASND
ASND
PLNT
PLNT
Q4 25
15.7%
Q3 25
23.2%
Q2 25
2.4%
Q1 25
40.1%
Q4 24
2.1%
Q3 24
26.7%
Q2 24
13.4%
Q1 24
25.6%
Capex Intensity
ASND
ASND
PLNT
PLNT
Q4 25
13.3%
Q3 25
16.6%
Q2 25
10.5%
Q1 25
8.3%
Q4 24
12.4%
Q3 24
16.6%
Q2 24
12.6%
Q1 24
10.6%
Cash Conversion
ASND
ASND
PLNT
PLNT
Q4 25
1.81×
Q3 25
2.23×
Q2 25
0.76×
Q1 25
3.20×
Q4 24
1.04×
Q3 24
3.02×
Q2 24
1.61×
Q1 24
2.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASND
ASND

Segment breakdown not available.

PLNT
PLNT

Corporate Owned Club Segment$135.6M36%
Equipment Revenue$121.2M32%
Franchise$98.6M26%
Advertising$20.8M6%
Related Party$4.3M1%

Related Comparisons